Helping Empower Liver and Kidney Patients
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
EBR/GZR for HCV-1b Patients Receiving Hemodialysis
- Status
- COMPLETED
- Phase
- PHASE4
Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
ERtugliflozin triAl in DIabetes With Preserved or Reduced ejeCtion FrAcTion mEchanistic Evaluation in Heart Failure
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Hepatitis C (HCV) Cure and Kidney Health
- Status
- UNKNOWN
- Phase
- N/A
Immunologic Determinants of Response to Pembrolizumab (MK-3475) in Advanced Melanoma (MK-3475-161/KEYNOTE-161)
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Self-efficacy, Beliefs and Adherence- Pilot and Feasibility Trial of a Pharmacist-led Intervention
- Status
- COMPLETED
- Phase
- NA
Pembrolizumab With Rituximab or Obinutuzumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of Pembrolizumab Following TACE in Primary Liver Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab, Capecitabine, and Bevacizumab for Treating Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary
- Status
- TERMINATED
- Phase
- PHASE2
Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001)
- Status
- COMPLETED
- Phase
- PHASE1
RESIST-2: 2nd-line ART for HIV-2 Infection
- Status
- TERMINATED
- Phase
- NA
Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2